Latest Breaking News On - University of texas at school medicine - Page 1 : comparemela.com

Peptilogics Strengthens Leadership Team with Three Strategic Appointments - Dr. David Huang, leader in anti-infective drug development, to serve as SVP, Chief Medical Officer - Dr. Nick Nystrom, global leader in life sciences AI, to serve as SVP, Computing & Data - Nicholas Pachuda, seasoned expert in business strategy, to serve as SVP, Portfolio Strategy & Development News provided by Share this article Share this article PITTSBURGH, March 17, 2021 /PRNewswire/  Peptilogics, a biotechnology platform company leveraging computational design to discover novel peptide therapeutics, announces the appointments of Dr. David Huang as SVP, CMO, Nick Nystrom as SVP, Computing & Data, and Nicholas Pachuda as SVP, Portfolio Strategy & Development. These leaders bring decades of experience in anti-infective drug development, orthopedic infection, computing and solutions architecture, and portfolio management. They join Peptilogics leadership team to help drive its lead peptide anti-inf

Nick nystromCarnegie mellonJonathan steckbeckNicholas pachudaDepuy synthesDavid huangPeter thielFounders fundX biotix pharmaceuticalsContrafect corpPortfolio strategy developmentSchool of public healthPittsburgh supercomputing centerUniversity of texas at school medicinePennsylvania college of podiatric medicineUniversity of pittsburgh